正念导向康复增强对阿片使用障碍前额叶皮层改变:随机临床试验
本随机临床试验在纽约住院康复机构纳入阿片使用障碍患者,比较正念导向康复增强(MORE)与心理教育支持治疗(PST)对脑功能及临床结局的影响。MORE减少药物线索反应中额中回等区域药物偏向活动,前额叶药物向自然奖赏反应转移与线索诱发渴求降低相关,并显著延长随访期戒断时间。
要点
- MORE较PST降低药物线索下调时额中回等区域药物偏向活动(z>3.1;P<.05)。
- 仅MORE组前额叶药物向自然奖赏反应转移与线索诱发渴求降低相关(z>3.1;P<.05)。
- MORE较PST减少内侧前额叶对药物相关电影场景同步(q=0.019)并延长戒断时间(χ2=6.7;P=.04)。
核心结论
- MORE可能重塑奖赏、显著性与控制网络前额叶节点功能,可作为阿片使用障碍药物治疗的生物学基础辅助干预。
研究设计与样本
- 随机临床试验于2020年11月至2024年9月在纽约住院康复机构招募阿片使用障碍患者,随机分入MORE或心理教育支持治疗(PST)。
- 干预为8次每周2小时团体治疗;MORE含正念训练、药物线索重评和积极体验品味,PST为活性对照。
- 药物线索反应任务分析纳入59例(MORE n=24;PST n=35),电影观看与随访分析分别纳入37例和38例子集。
主要发现
- 与PST相比,MORE在药物线索反应下调相对自然奖赏线索上调时,降低额中回及楔前叶等区域药物偏向活动(z>3.1;P<.05),控制被动观看线索后仍显著。
- 外侧与腹内侧前额叶从药物向自然奖赏反应转移与更低线索诱发渴求相关,仅见于MORE组(z>3.1;P<.05)。
- 与PST相比,MORE减少内侧前额叶对自然药物相关电影场景同步(q=0.019),并显著延长随访戒断时间(约治疗后4个月;χ2=6.7;P=.04;Cohen w=0.19)。
关键数值与推荐
- 主要结局为治疗相关fMRI血氧水平依赖信号变化;次要结局包括戒断时长和线索诱发渴求。
临床怎么用
- MORE可作为阿片使用障碍药物治疗的辅助心理干预,针对前额叶奖赏与线索反应环路改善渴求与戒断。
局限性
- 药物线索反应任务分析样本59例,电影观看与随访分析仅分别纳入37例和38例子集。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Despite decades of clinical implementation of medications for opioid use disorder (OUD), overdose mortality rates remain high, underscoring a critical need for interventions that target the brain mechanisms underlying addiction. OBJECTIVE: To assess the neural mechanisms of Mindfulness-Oriented Recovery Enhancement (MORE) and their associations with clinical outcomes, including craving and abstinence duration. DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial was conducted from November 2020 to September 2024 among individuals with OUD recruited from an inpatient rehabilitation facility in New York and randomized to MORE or psychoeducational supportive therapy (PST). Data were analyzed from October 2024 to August 2026. INTERVENTIONS: Treatment with MORE (comprising training in mindfulness, drug cue reappraisal, and savoring positive experiences) or PST (active control condition) across 8 weekly 2-hour group sessions. MAIN OUTCOMES AND MEASURES: Outcomes included treatment-related changes in functional magnetic resonance imaging (fMRI) blood oxygen level-dependent signal (primary), abstinence length (secondary), and cue-induced craving (secondary). RESULTS: Drug cue reactivity task analyses included 59 participants (MORE, n = 24; 5 women [20.8%]; mean [SD] age, 43.6 [11.3] years; PST, n = 35; 8 women [22.9%]; mean [SD] age, 42.8 [10.0] years). Movie-watching and follow-up analyses were conducted in subsets of 37 (MORE, n = 18; PST, n = 19) and 38 participants (MORE, n = 13; PST, n = 25), respectively. Compared with PST, MORE reduced drug-biased activity in the middle frontal gyrus and other brain areas, including the precuneus, during downregulation of responses to drug cues relative to upregulation of responses to natural reward cues (even when controlling for passive cue viewing; z > 3.1; P < .05). The shift from drug to natural reward responses in the lateral and ventromedial prefrontal cortex (PFC) was associated with lower cue-induced craving exclusively in the MORE group (z > 3.1; P < .05). Relative to PST, MORE also reduced medial PFC synchronization to naturalistic drug-related movie scenes (q = 0.019) and significantly extended abstinence duration at follow-up (approximately 4 months posttreatment; χ2 = 6.7; P = .04; Cohen w = 0.19). CONCLUSIONS AND RELEVANCE: This neuroimaging randomized clinical trial demonstrates that MORE may restructure function in PFC nodes of the reward, salience, and control networks, positioning it as a biologically grounded adjunct to pharmacotherapy for OUD. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04112186.
引用
- Huang, Ceceli, Kronberg, et al. Prefrontal Cortical Changes With Mindfulness-Oriented Recovery Enhancement in Opioid Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2026. PMID: 42949709. doi:10.1001/jamapsychiatry.2026.3388
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。